Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-Iodine vs Povidone-Iodine-Tetracycline for MPE Pleurodesis
NCT04039126Phase 1Unknown
- Sponsor
- University College Hospital, Ibadan
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tetracycline in malignant pleural effusion (MPE) (2 arms), sponsored by University College Hospital, Ibadan. Primary endpoint: Success of pleurodesis in controlling MPE at 3 months. Status: unknown.
02
Drugs
tetracycline
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT04039126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039126.